Fuad El-Hibri Blog

Fuad El-Hibri Appoints Allen Shofe Vice President of Government Affairs

June 15, 2009
1 Comment

Fuad El-Hibri appoints Allen Shofe Vice President of Government Affairs

Emergent BioSolutions Appoints Allen Shofe Vice President of Government Affairs

GAITHERSBURG, Md., Sept. 15 /PRNewswire/ — Emergent BioSolutions Inc. today announced the appointment of Allen Shofe to the position of Vice President of Government Affairs.  In this position, Mr. Shofe will be responsible for designing, implementing and overseeing all aspects of the company’s domestic and international government affairs initiatives.

“Allen is a versatile and highly astute government relations and public affairs executive,” said Fuad El-Hibri, CEO of Emergent BioSolutions.  “His government affairs expertise and extensive network of professional contacts throughout the United States and Europe will prove invaluable as we continue our efforts to become a global leader in our field.”

Mr. Shofe has more than 15 years experience in government relations and government affairs at the Federal and state levels, as well as in the international arena.  Mr. Shofe previously held the position of Director of Federal Government Relations at Eli Lilly and Company, where he managed a series of government initiatives, including those that focused on intellectual property, patent law and tort reform.  Mr. Shofe received his BA in International Relations/Diplomacy at the University of Minnesota and an LL.M, Master of Laws from the University of Leicester in the United Kingdom. “I look forward to the opportunity to help advance Emergent BioSolutions into a world class biopharmaceutical company,” said Mr. Shofe.  “This company has such a promising future, and to be a part of its growth and success is something I am extremely proud of.”

About Emergent BioSolutions
Emergent BioSolutions Inc., formed in 2004, is dedicated to the research, development and manufacture of novel products which harness the immune system to treat and prevent disease.  These include vaccines and related products for prophylactic and therapeutic use against common infectious diseases and biological weapons of mass destruction.  The company currently employs more than 450 people with facilities in Gaithersburg and Frederick, Maryland, Lansing, Michigan, Berkshire, U.K. and Munich Germany.  More information about Emergent BioSolutions and its subsidiaries can be found at http://www.ebsi.com

Reblog this post [with Zemanta]
Posted in Allen Shofe, El-Hibri Fuad, Emergent BioSolutions, Emergent BioSolutions Inc, Fuad El-Hibri
Tags: , , , , , , ,

About author

Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent), a publicly traded biopharmaceutical company focused on developing, manufacturing and commercializing vaccines and therapeutics to prevent and treat life-threatening diseases. The company’s current marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only FDA-licensed vaccine for pre-exposure prophylaxis of anthrax disease. The company is also investing heavily in the development of a broad pipeline of products that address specific global unmet medical needs, including Typhoid, Tuberculosis, Hepatitis B and Chlamydia. Mr. El-Hibri has extensive experience in the biopharmaceutical industry beginning with Porton Products, Ltd. (Porton), a mid-sized biotechnology company in the United Kingdom. Subsequent to the successful marketing and distribution of Porton’s biodefense vaccines to foreign governments in the early 1990’s, Mr. El-Hibri organized a management buyout of Porton in 1994, forming Speywood Holdings, Ltd. He was appointed to the Board of Directors of Speywood Holdings, Ltd. and acted as an advisor to the senior management team in the operations of the company until 1996. Starting in the 1990’s, Mr. El-hibri formed and then sold three mobile telecommunications companies, Mobile TeleSystems, serving the greater Moscow region, as well as Digitel and Digicel, serving markets in South and Central America. Mr. El-Hibri began his career with Citigroup in commercial banking and subsequently in mergers & acquisitions. Following his tenure at Citigroup, Mr. El-Hibri joined Booz Allen & Hamilton as a management consultant in South East Asia, where he led several large client engagements.

Search

Navigation

Categories:

Links:

Archives:

Feeds